Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Tritiated acetylcholine was used to measure binding sites with characteristics of nicotinic cholinergic receptors in rat brain. Regulation of the binding sites in vivo was examined by administering two drugs that stimulate nicotinic receptors directly or indirectly. After 10 days of exposure to the cholinesterase inhibitor diisopropyl fluorophosphate, binding of tritiated acetylcholine in the cerebral cortex was decreased. However, after repeated administration of nicotine for 10 days, binding of tritiated acetylcholine in the cortex was increased. Saturation analysis of tritiated acetylcholine binding in the cortices of rats treated with diisopropyl fluorophosphate or nicotine indicated that the number of binding sites decreased and increased, respectively, while the affinity of the sites was unaltered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been shown that high-dose chronic and intermittent nicotine exposure increases levels of high-affinity nicotinic receptors in adult humans and rodents (10–14).”
In the citing paper
“Repeated or prolonged nicotine exposure increases the number of high-affinity (mainly α4β2*) nicotine-binding sites, in heterologous systems (41, 42), nicotine-treated animals (11, 12), and in post mortem brains of smokers (ref. 10; for review, see ref. 43).”
In the citing paper
“animals exposed to nicotine chronically exhibit increased levels of nAChRs in the brain (Marks et al., 1983(Marks et al., , 1985(Marks et al., , 1992;;Schwartz and Kellar, 1983)”
From Human Tobacco Smokers in Early Abstinence Have Higher Levels of β2* Nicotinic Acetylcholine Receptors than Nonsmokers (2006) · cites this paper as Schwartz and Kellar, 1983
In the citing paper
“A hallmark of chronic nicotine administration is the upregulation of nicotinic receptors in the brain (Marks et al, 1983; Schwartz and Kellar, 1983) and recent studies in humans have suggested a functional role of these receptors in relapse vulnerability (Cosgrove et al, 2009).”
From Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal (2013) · cites this paper as Schwartz and Kellar, 1983
In the citing paper
“Chronic nicotine administration increases ␣42 neuronal nicotinic acetylcholine receptor (nAChR) density in brain.”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Schwartz and Kellar, 1983
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
Muscarinic Cholinergic Binding in Rat Brain
Yamamura, H. I., & Snyder, S. H. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.5.1725 · Cited by 1,203
Annual Review of Pharmacology,
Williams, J. F. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.1975.00330100136032 · Cited by 386
Stereospecific Nicotine Receptors on Rat Brain Membranes
Romano, C., & Goldstein, A. (1980) · Science · doi:10.1126/science.7433991 · Cited by 319
Receptor Adaptations to Centrally Acting Drugs
Creese, I., & Sibley, D. R. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.002041 · Cited by 290
THESLEFF, S. (1955) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1955.tb01242.x · Cited by 281
Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain.
Schwartz, R. D., McGee, R., & Kellar, K. J. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15102-x · Cited by 261
Self-citationNicotine-induced antinociception in rats and mice: correlation with nicotine brain levels.
Tripathi, H. L., Martin, B. R., & Aceto, M. D. (1982) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33022-3 · Cited by 171
The action potential of the superior cervical ganglion
Eccles, J. C. (1935) · The Journal of Physiology · doi:10.1113/jphysiol.1935.sp003313 · Cited by 165
Regulation of neocortical muscarinic receptors: effects of drug treatment and lesions
McKinney, M., & Coyle, J. (1982) · Journal of Neuroscience · doi:10.1523/jneurosci.02-01-00097.1982 · Cited by 156
Research works printed but not linked: 2
- DALE, H.H., J PHARMACOL EXP THER 6: 174 (1914).
- PORSIUS, A. J., ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 28: 1628 (1978).
Cited by
Items 101–200 of 481
Marks, M. J., Rowell, P. P., Cao, J., Grady, S. R., McCallum, S. E., & Collins, A. C. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.009 · Cited by 82
Effects of prenatal nicotine exposure on the morphogenesis of somatosensory cortex
Roy, T. S., & Sabherwal, U. (1994) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(94)90030-2 · Cited by 87
Lukas, R. J. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11403.x · Cited by 83
Collins, A. C., Romm, E., & Wehner, J. M. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90222-l · Cited by 79
Turner, J. R., Castellano, L. M., & Blendy, J. A. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq206 · Cited by 78
Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors
Henderson, B. J., Srinivasan, R., Nichols, W. A., Dilworth, C. N., Gutierrez, D. F., Mackey, E. D. W., McKinney, S., Drenan, R. M., Richards, C. I., & Lester, H. A. (2014) · Journal of General Physiology · doi:10.1085/jgp.201311102 · Cited by 78
Quirion, R., Araujo, D. M., Regenold, W. T., & Boksa, P. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90057-2 · Cited by 78
Counotte, D. S., Smit, A. B., Pattij, T., & Spijker, S. (2011) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2011.05.010 · Cited by 77
Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine
Ochoa, E. L. M., Li, L., & McNamee, M. G. (1990) · Molecular Neurobiology · doi:10.1007/bf02780343 · Cited by 82
Darsow, T., Booker, T. K., Piña-Crespo, J. C., & Heinemann, S. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501157200 · Cited by 76
Mitchell, S. N., Brazell, M. P., Joseph, M. H., Alavijeh, M. S., & Gray, J. A. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90440-8 · Cited by 80
Neurotrophic effects of central nicotinic receptor activation
Belluardo, N., Mudò, G., Blum, M., Amato, G., & Fuxé, K. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_15 · Cited by 76
Nicotinic acetylcholine receptor redux: Discovery of accessories opens therapeutic vistas
Matta, J. A., Gu, S., Davini, W. B., & Bredt, D. S. (2021) · Science · doi:10.1126/science.abg6539 · Cited by 82
Tolerance to nicotine following chronic treatment by injections: a potential role for corticosterone
Pauly, J. R., Grun, E. U., & Collins, A. C. (1992) · Psychopharmacology · doi:10.1007/bf02245282 · Cited by 77
McCallum, S. E., Collins, A. C., Paylor, R. E., & Marks, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0076-6 · Cited by 78
“…its relation to tolerance is still uncertain, upregulation of brain high-affinity agonist binding sites in laboratory animals (Marks et al. 1983; Schwartz and Kellar 1983) and smokers (Benwell et al. 1988; Breese et al.1997; Perry et al. 1999) is typically observed following chronic nicotine…”
BackgroundPartial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors
Hogg, R. C., & Bertrand, D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.010 · Cited by 76
Sunderland, T., Tariot, P. N., & NEWHOUSE, P. A. (1988) · Brain Research Reviews · doi:10.1016/0165-0173(88)90013-6 · Cited by 76
Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
Collins, A. C., Bhat, R. V., Pauly, J. R., & Marks, M. J. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470513965.ch5 · Cited by 73
Marks, M. J., McClure-Begley, T. D., Whiteaker, P., Salminen, O., Brown, R. W. B., Cooper, J., Collins, A. C., & Lindstrom, J. M. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178236 · Cited by 70
“…increases in high-affinity nicotinic receptor (nAChR) binding sites (termed up-regulation) in the brains of mice (Marks et al., 1983, 2004), rats (Schwartz and Kellar, 1983, 1985; Flores et al., 1992; Perry et al., 2007; Moretti et al., 2010), and humans (Benwell et al., 1988; Breese et al.,…”
BackgroundTolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine
Marks, M. J., & Collins, A. C. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90392-2 · Cited by 75
Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning
Gould, T. J., & Leach, P. T. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.08.004 · Cited by 67
Jeyarasasingam, G., Tompkins, L., & Quik, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00488-2 · Cited by 73
Pietilä, K., Lähde, T., Attila, M., Ahtee, L., & Nordberg, A. (1998) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005152 · Cited by 67
“By using this method, nicotine can be administered for several weeks (Nordberg et al. 1985; Pekonen et al. 1993) as compared with other routes of chronic nicotine administration such as continuous nicotine infusions and repeated subcutaneous injections (Hatchell and Collins 1977; Schwartz and Kellar 1983; Marks et al.…”
MethodPharmacological chaperoning of nAChRs: A therapeutic target for Parkinson's disease
Srinivasan, R., Henderson, B. J., Lester, H. A., & Richards, C. I. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.02.005 · Cited by 69
Nicotinic Acetylcholine Receptor
Maelicke, A. (1986) · Springer eBooks · doi:10.1007/978-3-642-71649-2 · Cited by 67
Sensitivity and tolerance to nicotine in smokers and nonsmokers
Srivastava, E. D., Russell, M. A. H., Feyerabend, C., Masterson, J. G., & Rhodes, J. (1991) · Psychopharmacology · doi:10.1007/bf02316865 · Cited by 67
“nicotinic receptors ( Schwartz and Kellar 1983; Marks et al. 1986).”
Comparative Analysis of Nicotine‐Like Receptor‐Ligand Interactions in Rodent Brain Homogenate
Larsson, C., & Nordberg, A. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb05469.x · Cited by 67
Srinivasan, R., Richards, C. I., Xiao, C., Rhee, D., Pantoja, R., Dougherty, D. A., Miwa, J. M., & Lester, H. A. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.077792 · Cited by 72
“The best-known effect of chronic exposure to nicotine is upregulation of nAChRs in vivo and in vitro, through celldelimited, post-translational mechanisms (Schwartz and Kellar, 1983; Peng et al., 1994; Gopalakrishnan et al., 1997; Buisson and Bertrand, 2002; Sallette et al., 2005; Nashmi et al., 2007; Lester et al., 2…”
BackgroundNicotine tolerance: an analysis of the time course of its development and loss in the rat
Collins, A. C., Romm, E., & Wehner, J. M. (1988) · Psychopharmacology · doi:10.1007/bf02431526 · Cited by 67
Recent progress in identifying nicotinic cholinoceptors in mammalian brain
Clarke, P. B. S. (1987) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(87)90031-9 · Cited by 69
Nicotine addiction and psychiatric disorders
Kutlu, M. G., Parikh, V., & Gould, T. J. (2015) · International Review of Neurobiology · doi:10.1016/bs.irn.2015.08.004 · Cited by 65
“…to desensitization as opposed to the α4β2 nAChRs (Alkondon & Albuquerque, 2004; Gotti et al., 2009; Marks, Burch, & Collins, 1983; Mihailescu & Drucker-Colin, 2000; Olale, Gerzanich, Kuryatov, Wang, & Lindstrom, 1997; Picciotto, Caldarone, King, & Zachariou, 2000; Schwartz & Kellar, 1983).”
Yates, S. L., Bencheri, M., Fluhler, E. N., & Lippiello, P. M. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02100-0 · Cited by 65
Cortical excitability in smoking and not smoking individuals with and without nicotine
Grundey, J., Freznosa, S., Klinker, F., Lang, N., Paulus, W., & Nitsche, M. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3125-6 · Cited by 76
“SAI is determined directly by the cholinergic system (Di Lazzaro et al. 2000), so up-regulation of nicotinic receptors by chronic nicotine consumption might have caused this effect in smokers (Hosur et al. 2009; Schwartz and Kellar 1983).”
BackgroundGrilli, M., Parodi, M., Raiteri, M., & Marchi, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03126.x · Cited by 65
Prendergast, M., Terry, A. V., & Buccafusco, J. J. (1997) · Psychopharmacology · doi:10.1007/s002130050179 · Cited by 65
“The development of tolerance or adaptation to OP agents has been well documented (Russell et al. 1979; Costa et al. 1982) and has been suggested to reflect the down regulation of ACh muscarinic (Schiller 1979; Schwartz and Kellar 1983; Bushnell et al. 1991; Yang et al. 1993) and nicotinic (Schwartz and Keller 1983) re…”
BackgroundReceptor mechanisms of nicotine-induced locomotor hyperactivity in chronic nicotine-treated rats
Fung, Y. K., & Lau, Y. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90721-2 · Cited by 72
Nordberg, A. K., Hartvig, P., Lundqvist, H., Antoni, G., Ulin, J., & Långström, B. (1989) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02248669 · Cited by 65
Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking
Ochoa, E. L. M., & Lasalde‐Dominicci, J. A. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9149-x · Cited by 67
“Galantamine has been already used to ameliorate alogia and the attentional and memory deficits of schizophrenic patients (Allen and McEvoy 2002; Rosse and Deutsch 2002; Ochoa and Clark 2004; Bora et al. 2005; Ochoa and Clark 2006; Schubert et al. 2006; Lee et al. 2007).”
BackgroundInfluentialClarke, P. B. S., Chaudieu, I., El‐Bizri, H., Boksa, P., Quik, M., Esplin, B. A., & Čapek, R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14748.x · Cited by 66
The role of corticosteroids in nicotine's physiological and behavioral effects
Caggiula, A. R., Donny, E. C., Epstein, L. H., Sved, A. F., Knopf, S., Rose, C., McAllister, C. G., Antelman, S. M., & Perkins, K. A. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00078-4 · Cited by 66
Sex differences in brain and behavior: emphasis on nicotine, nitric oxide and place learning
Pöğün, Ş. (2001) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(01)00168-4 · Cited by 69
The Chronic Administration of Nicotine Induces Cytochrome P450 in Rat Brain
Anandatheerthavarada, H. K., Williams, J. F., & Wecker, L. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13424.x · Cited by 63
Nicotine addiction: insights from recent animal studies
Mathieu-Kia, A.-M., Kellogg, S. H., Butelman, E. R., & Kreek, M. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1096-0 · Cited by 68
Conditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine
Caggiula, A. R., Epstein, L. H., Antelman, S. M., Saylor, S., Perkins, K. A., Knopf, S., & Stiller, R. L. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90319-w · Cited by 66
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Lower β2*-Nicotinic Acetylcholine Receptor Availability in Smokers With Schizophrenia
D'Souza, D. C., Esterlis, I., Carbuto, M., Krasenics, M., Seibyl, J., Bois, F., Pittman, B., Ranganathan, M., Cosgrove, K., & Staley, J. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020189 · Cited by 61
Historical and current perspective on tobacco use and nicotine addiction
Dani, J. A., & Balfour, D. J. K. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.001 · Cited by 81
Gäddnäs, H., Pietilä, K., & Ahtee, L. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00201-1 · Cited by 65
Ubiquilin-1 Regulates Nicotine-induced Up-regulation of Neuronal Nicotinic Acetylcholine Receptors
Ficklin, M. B., Zhao, S., & Feng, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506781200 · Cited by 59
Behavioral and Molecular Analysis of Nicotine-Conditioned Place Preference in Zebrafish
Kedikian, X., Faillace, M. P., & Bernabeu, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069453 · Cited by 64
“Early studies indicated that nicotine exposure increased the number of nAChR binding sites in the brains of rodents [15].”
BackgroundPauly, J. R., Grun, E. U., & Collins, A. C. (1990) · Psychopharmacology · doi:10.1007/bf02244047 · Cited by 62
“This tolerance is accompanied by an increase in CNS binding sites for nicotinic cholinergic ligands (the development of tolerance was most highly correlated with changes in sites labeled by [3HI-nicotine) ( Schwartz and Kellar 1983, 1985; Marks et al. 1985, 1986a, b). The finding that chronic nicotine treatment result…”
BackgroundRegulation of Brain Nicotinic Receptors by Chronic Agonist Infusion
Bhat, R. V., Turner, S. L., Selvaag, S. R., Marks, M. J., & Collins, A. C. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03450.x · Cited by 59
Wada, T., Naito, M., Kenmochi, H., Tsuneki, H., & Sasaoka, T. (2006) · Endocrinology · doi:10.1210/en.2006-0907 · Cited by 59
“In contrast, chronic nicotine administration in animal models is known to evoke a dose-dependent increase in the number of nicotinic receptors, especially in the brains of rats (32) and mice (33) as well as humans who have a lifelong history of smoking (41).”
BackgroundInfluentialMeyer, E. L., Xiao, Y., & Kellar, K. J. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12620-x · Cited by 35
Self-citationClarke, P. B. S., Reuben, M., & El-Bizri, H. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14793.x · Cited by 58
Gould, T. J., Portugal, G. S., André, J. M., Tadman, M. P., Marks, M. J., Kenney, J. W., Yildirim, E., & Adoff, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.003 · Cited by 56
“With chronic nicotine treatment, nAChRs upregulate (Marks et al., 1983; Schwartz and Kellar, 1983) and this upregulation lasts beyond cessation of nicotine treatment.”
Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents
Burch, J. B., de Fiebre, C. M., Marks, M. J., & Collins, A. C. (1988) · Psychopharmacology · doi:10.1007/bf00172954 · Cited by 56
“In order to explain this paradox, we (Marks et al, 1983) and others ( Schwartz and Kellar 1982 ) have suggested that most of the up-regulated nicotinic receptors are inactive or desensitized.”
BackgroundNicotinic acetylcholine receptors: upregulation, age‐related effects and associations with drug use
Melroy‐Greif, W. E., Stitzel, J. A., & Ehringer, M. A. (2016) · Genes, Brain and Behavior · doi:10.1111/gbb.12251 · Cited by 55
“However, the nicotine doses were slightly different than those used in the first studies showing upregulation; 2 mg/kg/h vs. 5 mg/kg/h nicotine (Marks et al. 1983) in mice and 6 mg/kg/day vs. 4 mg/kg/day (Schwartz & Kellar 1983) in rats.”
BackgroundMethodInfluentialInterplay between Smoking-induced Genotoxicity and Altered Signaling in Pancreatic Carcinogenesis
Momi, N., Kaur, S., Ponnusamy, M. P., Kumar, S., Wittel, U. A., & Batra, S. K. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs186 · Cited by 56
Smith, L. C., Kallupi, M., Tieu, L., Shankar, K., Jaquish, A. A., Barr, J., Su, Y., Velarde, N., Sedighim, S., Carrette, L. L. G., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0734-8 · Cited by 60
“Chronic nicotine use leads to the upregulation of nicotinic acetylcholine receptor binding sites in brain regions that modulate reward and stress in mice [62], rats [63], and humans [64].”
BackgroundNeurophysiology of Nicotine Addiction
Dani, J. A., Jenson, D., Broussard, J. I., & Biasi, M. D. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-001 · Cited by 59
“Nicotinic receptor upregulation differs among the diverse nAChR subtypes, varies among brain regions for the same nAChR subtype, and depends on the contingency of nicotine administration [62,63,82-86].”
BackgroundThe nicotinic cholinergic system function in the human brain
Nees, F. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.021 · Cited by 66
Mechanisms involved in the development of tolerance to DFP toxicity
Gupta, R. C. (1985) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(85)90111-3 · Cited by 53
Influence of kinetics of nicotine administration on tolerance development and receptor levels
Marks, M. J., Stitzel, J. A., & Collins, A. C. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90355-8 · Cited by 56
Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration
George, O., Lloyd, A., Carroll, F. I., Damaj, M. I., & Koob, G. F. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2024-3 · Cited by 53
“A prominent hypothesis in the nicotine addiction field is that upregulation of α4β2 nAChRs is a key element in nicotine dependence (Benwell et al. 1988; Breese et al. 1997; Marks et al. 1983, 1985, 1992; Schwartz and Kellar 1983), and that varenicline may be particularly efficient in reducing nicotine intake in depend…”
Miwa, J. M., Lester, H. A., & Walz, A. (2012) · Physiology · doi:10.1152/physiol.00002.2012 · Cited by 58
“Upregulation of 4 2 subunits is a well documented response to nicotine exposure and may underlie nicotine addiction (35, 72, 84, 109), and 4 nAChR subunits have been implicated in nicotine dependence in animal models (75, 116).”
BackgroundHuang, L. Z., & Winzer‐Serhan, U. H. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.084 · Cited by 54
El‐Bizri, H., & Clarke, P. B. S. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17080.x · Cited by 51
Effect of nicotine on cerebellar granule neuron development
Opanashuk, L. A., Pauly, J. R., & Hauser, K. F. (2001) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2001.01359.x · Cited by 51
“Chronic exposure to nicotinic agonists causes a dosedependent increase in the density of brain a4 AChRs, possibly as a result of desensitization or permanent inactivation (Schwartz & Kellar, 1983; Pauly et al., 1991; Collins & Marks, 1996; Changeux et al., 1998).”
BackgroundResting-state EEG, Substance use and Abstinence After Chronic use: A Systematic Review
Liu, Y., Chen, Y., González, G. F., Szpak, V., Laverman, J., Wiers, R. W. H. J., & Ridderinkhof, K. R. (2022) · Clinical EEG and Neuroscience · doi:10.1177/15500594221076347 · Cited by 61
“These alterations may reflect the upregulated nicotine cholinergic receptors caused by chronic smoking.(94) On the other hand, tobacco deprivation (a couple of hours to 31 days) consistently produced an increase in theta power and decreased dominant alpha frequency, which usually peaked within the first day and could…”
BackgroundUnderstanding the Toxic Actions of Organophosphates
Savolainen, K. (2001) · Elsevier eBooks · doi:10.1016/b978-012426260-7.50053-7 · Cited by 64
Chronic nicotine administration in the drinking water affects the striatal dopamine in mice
Pietilä, K., & Ahtee, L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00235-5 · Cited by 50
Froeliger, B., Kozink, R. V., Rose, J. E., Behm, F. M., Salley, A. N., & McClernon, F. J. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1862-3 · Cited by 49
“Chronic nicotine exposure leads to increased nicotinic receptor density throughout the brain (Marks et al. 1983; Schwartz and Kellar 1983) and the largest magnitude of increase occurs in the hippocampus (Benwell et al.”
BackgroundNicotine and Behavioral Sensitization
Mao, D., & McGehee, D. S. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9230-7 · Cited by 47
“…pharmacological and biophysical properties, nAChR upregulation following pre-exposure to nicotine varies with subunit composition, cell type, and brain region (Buisson and Bertrand 2001; Flores et al. 1992; Marks et al. 1983; Nguyen et al. 2003; Perry et al. 2007; Schwartz and Kellar 1983, 1985).”
Zhao, C., Noack, C., Brackmann, M., Gloveli, T., Maelicke, A., Heinemann, U., Anand, R., & Braunewell, K. H. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.11.001 · Cited by 56
“…results initially in receptor desensitization (Giniatullin et al., 2005), followed by subsequent functional up-regulation of high affinity nicotine binding sites (Schwartz and Kellar, 1983), thus most likely enhancing release of dopamine in the mesolimbic rewarding system (Dani et al., 2001).”
BackgroundMcCallum, S. E., Parameswaran, N., Bordia, T., Fan, H., McIntosh, J. M., & Quik, M. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104414 · Cited by 48
“The 4 2* nAChR population is increased in rodent brain, with chronic nicotine treatment, and is also elevated in the brains of smokers (Marks et al., 1983; Schwartz and Kellar, 1983; Benwell et al., 1988).”
BackgroundQuantitative autoradiography of nicotinic [3H]acetylcholine binding sites in rat brain
Rainbow, T. C., Schwartz, R. D., Parsons, B., & Kellar, K. J. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90485-3 · Cited by 48
Self-citationDhara, M., Matta, J. A., Lei, M., Knowland, D., Yu, H. Y., Gu, S., & Bredt, D. S. (2020) · Nature Communications · doi:10.1038/s41467-020-16629-3 · Cited by 55
Effect of long-term nicotine treatment on [3H] nicotine binding sites in the rats brain
Nordberg, A. K., Wahlström, G., Arnelo, U., & Larsson, C. U. (1985) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(85)90077-8 · Cited by 49
Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence
Turner, J. R., Ray, R., Lee, B., Everett, L. J., Xiang, J. J., Jepson, C., Kaestner, K. H., Lerman, C. E., & Blendy, J. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.104 · Cited by 50
Nakazato, T., & Akiyama, A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02238-2 · Cited by 48
Booker, T. K., & Collins, A. C. (1997) · Alcohol · doi:10.1016/s0741-8329(96)00116-4 · Cited by 47
Wu, M., Puddifoot, C. A., Taylor, P., & Joiner, W. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.647248 · Cited by 52
Modulation of acetylcholine release by nicotinic receptors in the rat brain
De Sarno, P., & Giacobini, E. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490220213 · Cited by 45
“By contrast, repeated administrations of a nicotinic agonist (nicotine) increased the number of nicotinic (3H-ACh) recognition sites but not of muscarinic (3H-QNB) sites (Schwartz and Kellar, 1983).”
Counotte, D. S., Goriounova, N. A., Moretti, M., Smoluch, M. T., Irth, H., Clementi, F., Schoffelmeer, A. N. M., Mansvelder, H. D., Smit, A. B., Gotti, C., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-198994 · Cited by 44
McCallum, S. E., Parameswaran, N., Bordia, T., Fan, H., Tyndale, R. F., Langston, J. W., McIntosh, J. M., & Quik, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03646.x · Cited by 44
“…binding sites are generally increased with long-term nicotine exposure both in experimental models and in the brains of smokers (Marks et al. 1983; Schwartz and Kellar 1983, 1985; Benwell et al. 1988; Peng et al. 1994; Breese et al. 1997; Whiteaker et al. 1998; Perry et al. 1999; Teaktong et al.…”
Welzl, H., Alessandri, B., Oettinger, R., & B�ttig, K. (1988) · Psychopharmacology · doi:10.1007/bf00216057 · Cited by 44
Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation
Nashmi, R., & Lester, H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.040 · Cited by 43
“Nearly a quarter-century ago, pioneering studies in vivo using radio-ligand binding showed that chronic nicotine administered to rodents results in elevated levels of nicotinic receptors [7,8].”
BackgroundCellular and molecular mechanisms of drug dependence: An overview and update
Kulhara, P., & Gupta, S. (2007) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.33253 · Cited by 50
Behavioural Pharmacology and Neurobiology of Nicotine Reward and Dependence
Chiara, G. D. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_24 · Cited by 51
Involvement of cholinergic mechanisms in the behavioral effects of dietary fat consumption
Morganstern, I., Ye, Z., Liang, S., Fagan, S. E., & LEIBOWITZ, S. F. (2012) · Brain Research · doi:10.1016/j.brainres.2012.06.004 · Cited by 48
“…subtypes after HFD consumption, an effect similar to that occurring with prolonged nicotine treatment (Flores et al., 1997; Rasmussen and Perry, 2006; Schwartz and Kellar, 1983), it is likely that mecamylamine by blocking these receptor sites can attenuate the behavioral abnormalities induced by a…”
Attentional performance of (C57BL/6J×129Sv)F2 mice in the five-choice serial reaction time task
de Bruin, N. M. W. J., Fransen, F., Duytschaever, H., Grantham, C. A., & Megens, A. A. H. P. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.08.009 · Cited by 49
Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT.
Fujita, M., Tamagnan, G. D., Zoghbi, S. S., Al‐Tikriti, M. S., Baldwin, R. M., Seibyl, J. P., & Innis, R. B. (2000) · PubMed · Cited by 46
Dávila‐García, M. I., Musachio, J. L., & Kellar, K. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01774.x · Cited by 42
Self-citationInfluence of development and aging on nicotinic receptor subtypes in rodent brain
Zhang, X., Wahlström, G., & Nordberg, A. (1990) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(90)90065-a · Cited by 42
Pakkanen, J. S., Jokitalo, E., & Tuominen, R. K. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04105.x · Cited by 43
“Chronic nicotine treatment up-regulates the number of nAChRs in the brain (Schwartz & Kellar, 1983; Wonnacott, 1990).”
BackgroundNicotinic Receptors, Memory, and Hippocampus
Kutlu, M. G., & Gould, T. J. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_6 · Cited by 47
Avila, A. M., Dávila‐García, M. I., Ascarrunz, V. S., Xiao, Y., & Kellar, K. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.974 · Cited by 43
“Previous studies have shown that chronic administration of nicotine increases nicotinic receptor binding sites in rat and mouse brain (Schwartz and Kellar, 1983; Marks et al., 1983; for review, see Gentry and Lukas, 2002), and a similar increase is found in human brains from people who smoked…”
BackgroundSelf-citationQuik, M., Polonskaya, Y., Gillespie, A. J., Lloyd, G. K., & Langston, J. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00244-x · Cited by 42
Effects of Mecamylamine on Spontaneous EEG and Performance in Smokers and Non-Smokers
Pickworth, W. B., Fant, R. V., Butschky, M. F., & Henningfield, J. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00183-9 · Cited by 41
Metadata
- Authors
- Schwartz, R. D., & Kellar, K. J.
- Affiliations
- Georgetown University (US)
- ORCID
- Kellar, Kenneth J.
- Venue
- Science
- Published
- 1983-04-08
- Volume
- 220
- Issue
- 4593
- Pages
- 214-216
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2091374932
- Cited by
- 479
- References
- 17
- Citations by year
- 2025: 1 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 3 · 2020: 14 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 11 · 2015: 12 · 2014: 13 · 2013: 17 · 2012: 19
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, receptor binding sites, diisopropylfluorophosphate, nicotine, cholinesterase inhibition, cerebral cortex, receptor regulation, receptor density, receptor binding affinity, saturation analysis
- MeSH terms
- Acetylcholine, Animals, Brain, Brain Chemistry, Cerebral Cortex, Isoflurophate, Male, Nicotine, Rats, Inbred Strains, Receptors, Cholinergic, Receptors, Nicotinic, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.